These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 2961902)
21. Administration of nonanticoagulant heparin inhibits the loss of glycosaminoglycans from xenogeneic cardiac grafts and prolongs graft survival. Stevens RB; Wang YL; Kaji H; Lloveras J; Dalmasso A; Bach FH; Rubinstein P; Sutherland DE; Platt JL Transplant Proc; 1993 Feb; 25(1 Pt 1):382. PubMed ID: 8438344 [No Abstract] [Full Text] [Related]
22. Amphiregulin-dependent proliferation of cultured human keratinocytes: autocrine growth, the effects of exogenous recombinant cytokine, and apparent requirement for heparin-like glycosaminoglycans. Piepkorn M; Lo C; Plowman G J Cell Physiol; 1994 Apr; 159(1):114-20. PubMed ID: 8138579 [TBL] [Abstract][Full Text] [Related]
23. The endothelial heparan sulfate-antithrombin III natural anticoagulant pathway in normal and transplanted human kidneys. Absher E; Labarrere CA; Carter C; Haag B; Faulk WP Transplantation; 1992 Apr; 53(4):828-34. PubMed ID: 1566349 [TBL] [Abstract][Full Text] [Related]
24. Role of endothelial cell surface heparin-like polysaccharides. Marcum JA; Rosenberg RD Ann N Y Acad Sci; 1989; 556():81-94. PubMed ID: 2660690 [No Abstract] [Full Text] [Related]
25. Association of thrombospondin of endothelial cells with other matrix proteins and cell attachment sites and migration tracks. Vischer P; Völker W; Schmidt A; Sinclair N Eur J Cell Biol; 1988 Oct; 47(1):36-46. PubMed ID: 3229419 [TBL] [Abstract][Full Text] [Related]
26. Effect of glycosaminoglycans on the growth of cultured tumor cells. Nagasawa S J Osaka Dent Univ; 1993 Oct; 27(2):121-33. PubMed ID: 8182504 [TBL] [Abstract][Full Text] [Related]
27. Antithrombin III metabolism in the pulmonary vessel endothelium. Proietta M; Pulignano I; Del Porto F; Tritapepe L; Di Giovanni C; Caronti B; Guglielmi R; Aliberti G Blood Coagul Fibrinolysis; 2007 Apr; 18(3):237-40. PubMed ID: 17413759 [TBL] [Abstract][Full Text] [Related]
28. Interaction of heparan sulfate and its fractions with endothelial cells in culture. Tiozzo R; Cingi MR; Croce MA Int J Tissue React; 1993; 15(4):163-8. PubMed ID: 8188456 [TBL] [Abstract][Full Text] [Related]
29. IGFBP-3 and IGFBP-5 association with endothelial cells: role of C-terminal heparin binding domain. Booth BA; Boes M; Andress DL; Dake BL; Kiefer MC; Maack C; Linhardt RJ; Bar K; Caldwell EE; Weiler J Growth Regul; 1995 Mar; 5(1):1-17. PubMed ID: 7538367 [TBL] [Abstract][Full Text] [Related]
30. [Structures and biological activities of heparin-like molecules]. Itano N; Okayama M Seikagaku; 1992 Jul; 64(7):513-20. PubMed ID: 1402210 [No Abstract] [Full Text] [Related]
31. Studies of heparin binding to antithrombin III by crossed immunoelectrophoresis. Barrowcliffe TW Thromb Haemost; 1980 Feb; 42(5):1434-45. PubMed ID: 7368150 [TBL] [Abstract][Full Text] [Related]
33. Is heparan sulphate the agent of the amphibian inductor? Landström U; Lovtrup S Acta Embryol Exp (Palermo); 1977 Sep; (2):171-8. PubMed ID: 144395 [No Abstract] [Full Text] [Related]
34. Heparin-like polysaccharides in intra- and extravascular coagulation reactions. Lindahl U; Pejler G Acta Med Scand Suppl; 1987; 715():139-44. PubMed ID: 2954435 [No Abstract] [Full Text] [Related]
35. Shedding of heparan sulfate proteoglycan by stimulated endothelial cells: evidence for proteolysis of cell-surface molecules. Ihrcke NS; Platt JL J Cell Physiol; 1996 Sep; 168(3):625-37. PubMed ID: 8816917 [TBL] [Abstract][Full Text] [Related]
36. Enzymatic lysis of sulfated glycosaminoglycans reduces the electrophoretic mobility of vascular endothelial cells. Vargas FF; Osorio HM; Basilio C; De Jesus M; Ryan US Membr Biochem; 1990; 9(2):83-9. PubMed ID: 2103936 [TBL] [Abstract][Full Text] [Related]
37. Role of antithrombin III as a regulator of in vivo coagulation. Bauer KA; Rosenberg RD Semin Hematol; 1991 Jan; 28(1):10-8. PubMed ID: 2017686 [No Abstract] [Full Text] [Related]
38. Thrombogenicity of the injured vessel wall--role of antithrombin and heparin. Frebelius S; Hedin U; Swedenborg J Thromb Haemost; 1994 Jan; 71(1):147-53. PubMed ID: 8165634 [TBL] [Abstract][Full Text] [Related]